EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Furopyridine Derivatives as Potent Inhibitors of the Wild Type, L858R/T790M, and L858R/T790M/C797S EGFR

Duangjai Todsaporn, Alexander Zubenko, Victor G Kartsev, Panupong Mahalapbutr iD, Athina Geronikaki, Samvel N Sirakanyan, Lyudmila N Divaeva, Victoria Chekrisheva, Ilkay Yildiz, Kiattawee Choowongkomon iD, Thanyada Rungrotmongkol iD

The Journal of Physical Chemistry B · 2024

DOI: 10.1021/acs.jpcb.4c06246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, 2024. Verfasst von Duangjai Todsaporn und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Biocatalyst and Sustainable Biotechnology, Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok …. Hauptthemen laut MEDLINE: ErbB Receptors, Pyridines, Protein Kinase Inhibitors, Molecular Dynamics Simulation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Office of National Higher Education Science Research and Innovation Policy Council, Chulalongkorn University, Fundamental Scientific Research of the State Academies of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsPyridinesProtein Kinase InhibitorsMolecular Dynamics SimulationMolecular Docking SimulationMutationHumansAntineoplastic AgentsCarcinoma, Non-Small-Cell LungCell Line, TumorFuransMolecular StructureLung Neoplasms

Substanzen

ErbB ReceptorsPyridinesProtein Kinase InhibitorsEGFR protein, humanAntineoplastic AgentsFurans

Autor:innen und Institutionen

  • Center of Excellence in Biocatalyst and Sustainable Biotechnology, Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.
  • North-Caucasian Zonal Research Veterinary Institute, 346406 Novocherkassk, Russia.
  • InterBioScreen, 85355 Moscow, Russia.
  • Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Department of Pharmaceutical Chemistry, School of Health, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.
  • The Scientific Technological Center of Organic and Pharmaceutical Chemistry, Armenian Academy of Science, Institute of Fine Organic Chemistry of A.L. Mnjoyan, Avenue Azatutyan 26, Yerevan 0014, Armenia.

ORCID-Profile: Panupong Mahalapbutr, Kiattawee Choowongkomon, Thanyada Rungrotmongkol

Förderung

  • Office of National Higher Education Science Research and Innovation Policy Council
  • Chulalongkorn University
  • Fundamental Scientific Research of the State Academies of Sciences
  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Todsaporn, D., Zubenko, A., Kartsev, V. G., Mahalapbutr, P., Geronikaki, A., Sirakanyan, S. N., Divaeva, L. N., Chekrisheva, V., Yildiz, I., Choowongkomon, K., & Rungrotmongkol, T. (2024). Furopyridine Derivatives as Potent Inhibitors of the Wild Type, L858R/T790M, and L858R/T790M/C797S EGFR. The Journal of Physical Chemistry B. https://doi.org/10.1021/acs.jpcb.4c06246

Vancouver

Todsaporn D, Zubenko A, Kartsev VG, Mahalapbutr P, Geronikaki A, Sirakanyan SN, et al. Furopyridine Derivatives as Potent Inhibitors of the Wild Type, L858R/T790M, and L858R/T790M/C797S EGFR. The Journal of Physical Chemistry B. 2024. doi:10.1021/acs.jpcb.4c06246

BibTeX
@article{Todsaporn2024,
  author = {Todsaporn, Duangjai and Zubenko, Alexander and Kartsev, Victor G and Mahalapbutr, Panupong and Geronikaki, Athina and Sirakanyan, Samvel N and Divaeva, Lyudmila N and Chekrisheva, Victoria and Yildiz, Ilkay and Choowongkomon, Kiattawee and Rungrotmongkol, Thanyada},
  title = {Furopyridine Derivatives as Potent Inhibitors of the Wild Type, L858R/T790M, and L858R/T790M/C797S EGFR},
  journal = {The Journal of Physical Chemistry B},
  year = {2024},
  doi = {10.1021/acs.jpcb.4c06246}
}
Kostenlos starten →